Marathon Pharmaceuticals Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 4

  • Investments
  • 4

Marathon Pharmaceuticals General Information

Description

Developer of pharmaceuticals to treat rare diseases for high need populations. The company offers non-selective central nervous system depressants that are used as sedative hypnotics, pharmaceutical for the treatment of diarrhea and pharmaceutical for the short-term treatment of insomnia and used as preanesthetic before surgery.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Corporate Office
  • 1033 Skokie Boulevard
  • Suite 600
  • Northbrook, IL 60062
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Marathon Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Marathon Pharmaceuticals‘s full profile, request access.

Request a free trial

Marathon Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceuticals to treat rare diseases for high need populations. The company offers non-selective central
Pharmaceuticals
Northbrook, IL
51 As of 2016
00000000000

000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
000000000000000
Menlo Park, CA
000 As of 0000
00000
00000000000 00000

000000

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in rep
000000000000000
Karachi, Pakistan
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Marathon Pharmaceuticals Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corcept Therapeutics Formerly VC-backed Menlo Park, CA 000 00000 00000000000 00000
Pfizer Pakistan Corporation Karachi, Pakistan
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA 0000 00000 0000 00000
Camurus Corporation Lund, Sweden 000 00000 000000000 00000
GlaxoSmithKline Consumer Nigeria Corporation Lagos, Nigeria 00 00000000
You’re viewing 5 of 29 competitors. Get the full list »

Marathon Pharmaceuticals Patents

Marathon Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20050233966-A1 Inhibiting angiogenesis by administering thrombin inhibitor (hirudins) alone, or with anticancer or cytotoxic agent; sustained release Active 12-Apr-2004 000000000 00
US-7795205-B2 Inhibiting angiogenesis by administering thrombin inhibitor (hirudins) alone, or with anticancer or cytotoxic agent; sustained release Active 12-Apr-2004 000000000 00
US-6436901-B1 Composition comprising hirudin, potassium phosphate and sugar, prepared by forming isotonic solution of hirudin, dipotassium hydrogen phosphate, and selected sugar at specified hirudin concentration and freeze drying solution Inactive 26-Jan-1994 000000000 00
US-5733874-A Comprising hirudin and a water-soluble salt seleccted from calcium or magnesium chloride or magnesium sulfate Inactive 26-Jan-1994 000000000 0
US-5472938-A Sustained release formulation containing water and calcium, magnesium or zinc ions in the form of water insoluble salts Inactive 18-Feb-1993 A61K47/02 0
To view Marathon Pharmaceuticals’s complete patent history, request access »

Marathon Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Marathon Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Marathon Pharmaceuticals‘s full profile, request access.

Request a free trial

Marathon Pharmaceuticals Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ReAlta Life Sciences 28-Apr-2021 00000 0000 000.00 Drug Discovery
ReAlta Life Sciences 21-Apr-2020 00000 0000 0000 Drug Discovery
Norphan Pharmaceuticals 01-Jan-2013 0000000000 Pharmaceuticals
Bentus Laboratories 01-Dec-2009 Later Stage VC 000 Pharmaceuticals
To view Marathon Pharmaceuticals’s complete investments and acquisitions history, request access »

Marathon Pharmaceuticals FAQs

  • Who is the founder of Marathon Pharmaceuticals?

    Jeffrey Aronin is the founder of Marathon Pharmaceuticals.

  • Where is Marathon Pharmaceuticals headquartered?

    Marathon Pharmaceuticals is headquartered in Northbrook, IL.

  • What is the size of Marathon Pharmaceuticals?

    Marathon Pharmaceuticals has 51 total employees.

  • What industry is Marathon Pharmaceuticals in?

    Marathon Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Marathon Pharmaceuticals a private or public company?

    Marathon Pharmaceuticals is a Private company.

  • What is Marathon Pharmaceuticals’s current revenue?

    The current revenue for Marathon Pharmaceuticals is 000000.

  • Who are Marathon Pharmaceuticals’s investors?

    Ligand Pharmaceuticals and Valor Equity Partners have invested in Marathon Pharmaceuticals.

  • Who are Marathon Pharmaceuticals’s competitors?

    Corcept Therapeutics, Pfizer Pakistan, BioMarin Pharmaceutical, Camurus, and GlaxoSmithKline Consumer Nigeria are some of the 29 competitors of Marathon Pharmaceuticals.

  • When was Marathon Pharmaceuticals acquired?

    Marathon Pharmaceuticals was acquired on 01-Oct-2015.

  • Who acquired Marathon Pharmaceuticals?

    Marathon Pharmaceuticals was acquired by CoPharma (United States).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »